// App-Quantinova.ai

e16146 : Detection of early recurrence in HCC patients after TACE treatment with plasma cfDNA.

Researchers

Presenter

  • Xiao Du

Principal Investigators

  • Zhen Li

  • Henghui Zhang

Medical Centers

  • Beijing Genecast Biotechnology Co., Beijing, China

  • Department of Interventional Therapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

  • Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, Beijing, China

Locations

  • China

Companies

  • Genecast Biotechnolo

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Alpha-fetoprotein

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved